Aliso Viejo-based Valeant Pharmaceuticals International said Thursday that it has completed its acquisition of Coria Laboratories Ltd. The deal was worth $95M. Valeant had originally announced the acquisition of Coria Laboratories from its parent company, DFB Pharmaceuticals, on September 17th. Coria Laboratories is focused on dermatology products.